Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darcy A Krueger, MD, PhD
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Martina Bebin, MD, MPA
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
E. Martina Bebin, MD, MPARecruiting - University of California at Los Angeles
Los Angeles, California, United States
Rajsekar Rajamaran, MD, MSRecruiting - Stanford University
Palo Alto, California, United States
Brenda Porter, MDRecruiting - Children'S Hospital Colorado
Aurora, Colorado, United States
Kevin Ess, MDRecruiting - Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Tracy Gertler, MDRecruiting - Boston Children'S Hospital
Boston, Massachusetts, United States
Mustafa Sahin, MD, PhDRecruiting - Washington University -- St. Louis
St Louis, Missouri, United States
Michael Wong, MD, PhDRecruiting - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Active, not recruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Darcy A Krueger, MD, PhDRecruiting - University of Texas Hsc at Houston
Houston, Texas, United States
Hope Northrup, MDRecruiting - Seattle Children'S Hospital
Seattle, Washington, United States
Stephanie Randle, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Oct 2021
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2027
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 64
- Registry id
- NCT05104983
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.